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(PEmax) and inspiratory pressures (Plmax) were clearly reduced to 56 (17)% and 76 (28)% respectively. This suggests that spirometrically determined volumes were better preserved than respiratory muscle strength in ankylosing spondylitis. It is speculated that the reduction in respiratory muscle strength may be due to intercostal muscle atrophy.
Ankylosing spondylitis is a systemic rheumatic disease. Involvement of the lungs with a reduction in lung volumes is a well known manifestation of this disease, presumably resulting from a reduction in thoracic mobility.1 No data are available, however, on respiratory muscle strength in patients with ankylosing spondylitis.
This study was designed to evaluate respiratory muscle function and strength by measurement of the maximal transrespiratory pressures as well as lung volumes in ankylosing spondylitis.
Patients and methods
We examined 30 patients meeting the criteria of definite ankylosing spondylitis according to the American Rheumatism Association (New York). (Table 2 ) correlated with pulmonary function tests ( Table 3 ). The best correlations were observed between vital capacity and chest expansion (p<0.001), followed by the correlation between vital capacity and Schober index (p<0-01). A good inverse relation between vital capacity and fingertip to floor distance was present (p<0-01). We noticed, however, that patients with a markedly reduced thorax expansion (14 mm or less) still had a vital capacity that was 62% of predicted values. Table 4 summarises these correlations. Table 5 summarises the relation between thorax expansion and lung volumes.
MAXIMAL TRANSRESPIRATORY PRESSURES
Maximal transrespiratory pressures were significantly These correlations between vital capacity and thorax expansion of Schober index may be affected by variability in spinal mobility and chest expansion as these vary with age and sex, and, moreover, may be influenced by artefacts related to measurement techniques.'1 12 These artefacts were minimised by measuring chest wall expansion while the patient stood with hands on head, and arms flexed in a frontal plane. Unexpectedly, however, patients with ankylosing spondylitis with a markedly reduced thorax expansion (less than 14 mm) still had an average vital capacity of 62% of the predicted value. This could either mean that the diaphragm contributes the greatest part to vital capacity or that it partly compensates for the loss of thoracic expansion. The latter phenomenon is certainly present during tidal breathing as it is a-common clinical observation that patients with ankylosing spondylitis have enhanced inspiratory abdominal outward motion. Previous studies have suggested that the diaphragmatic contribution to inhaled volume increases as a direct consequence of ankylosis of the thoracic cage. 5 6 8 9 1315 The compensatory effort of the diaphragm is a probable explanation of the fact that patients with ankylosing spondylitis have only mild respiratory discomfort or none at all. We have occasionally noticed that patients with ankylosing spondylitis with unilateral diaphragmatic paralysis have pronounced dyspnoea together with a marked reduction of the vital capacity.
It is known that other deformities, such as kyphoscoliosis, are usually accompanied by more severe abnormalities of lung function.4 This is probably partly due to the presence of thoracic deformity and may be partly due to other factors, such as fixation changes of the thorax in ankylosing spondylitis at a lung volume higher than the relaxation volume of the thorax. 6 
